Prenatal Treatment Path for Angelman Syndrome and Other Neurodevelopmental Disorders

Autism Research : Official Journal of the International Society for Autism Research
Mark J Zylka


Angelman syndrome (AS) is a rare neurodevelopmental disorder caused by mutation or deletion of the maternally inherited UBE3A allele. These pathogenic mutations lead to loss of maternal UBE3A expression in neurons. Antisense oligonucleotides and gene therapies are in development, which activate the intact but epigenetically silenced paternal UBE3A allele. Preclinical studies indicate that treating during the prenatal period could greatly reduce the severity of symptoms or prevent AS from developing. Genetic tests can detect the chromosome 15q11-q13 deletion that is the most common cause of AS. New, highly sensitive noninvasive prenatal tests that take advantage of single-cell genome sequencing technologies are expected to enter the clinic in the coming years and make early genetic diagnosis of AS more common. Efforts are needed to identify fetuses and newborns with maternal 15q11-q13 deletions and to phenotype these babies relative to neurotypical controls. Clinical and parent observations suggest AS symptoms are detectable in infants, including reports of problems with feeding and motor function. Quantitative phenotypes in the 0- to 1-year age range will permit a more rapid assessment of efficacy when future treatments are adm...Continue Reading


Sep 10, 1998·Pediatric Neurosurgery·Noel B Tulipan, J P Bruner
Sep 24, 2004·Human Molecular Genetics·Hülya NazlicanBernhard Horsthemke
Nov 4, 2004·Clinical Genetics·S U PetersC A Bacino
Feb 5, 2005·Fetal Diagnosis and Therapy·Britta ChristensenHenning Djursing
Feb 14, 2006·American Journal of Medical Genetics. Part a·Charles A WilliamsJoseph Wagstaff
Aug 8, 2007·Seminars in Fetal & Neonatal Medicine·Frank A Chervenak, Laurence B McCullough
Mar 5, 2008·Paediatric Anaesthesia·Jeffrey C GardnerDouglas G Ririe
Apr 27, 2010·Developmental Disabilities Research Reviews·Jack M Fletcher, Timothy J Brei
Dec 22, 2010·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Judith BenkendorfMichael S Watson
Feb 11, 2011·The New England Journal of Medicine·N Scott AdzickMOMS Investigators
May 20, 2011·Trends in Neurosciences·Angela M MabbBenjamin D Philpot
Dec 23, 2011·Nature·Hsien-Sung HuangBenjamin D Philpot
Jan 9, 2013·Behavioural Brain Research·Hsien-Sung HuangSheryl S Moy
Apr 26, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alan D WorkmanBarbara L Finlay
Jun 10, 2014·JAMA Pediatrics·Ariane V S BuescherDavid S Mandell
Jun 24, 2014·American Journal of Obstetrics and Gynecology·Sebastian LarionAlfred Z Abuhamad
Nov 19, 2014·Proceedings of the National Academy of Sciences of the United States of America·Angela M MabbMark J Zylka
Dec 6, 2014·American Journal of Obstetrics and Gynecology·Ronald WapnerPeter Benn
Feb 25, 2015·Molecular Psychiatry·B W M van BonE E Eichler
Apr 14, 2015·The Journal of Clinical Investigation·Sara Silva-SantosYpe Elgersma
May 30, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christian HindererJames M Wilson
Aug 25, 2015·JAMA Neurology·Mark H TuszynskiAlan H Nagahara
Oct 9, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·J Christopher EhlenJason P DeBruyne
Nov 21, 2015·Epigenomics·Janine M LaSalleStormy J Chamberlain
Jan 5, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Barbara J BailusDavid J Segal
Jun 9, 2016·Human Gene Therapy·Michaël HocquemillerNathalie Cartier
Aug 17, 2016·Obstetrical & Gynecological Survey·Matthew R GraceJeffrey A Kuller
Nov 20, 2016·Human Gene Therapy. Clinical Development·Thomas J ConlonBarry J Byrne
Feb 18, 2017·American Journal of Medical Genetics. Part a·Anna Le FevreTracy Dudding-Byth
Mar 11, 2017·Human Gene Therapy. Clinical Development·Yoshihide SeharaShin-Ichi Muramatsu
Apr 21, 2017·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Elly ScheermeyerPWS and OZGROW collaboration
Apr 30, 2017·Science·Michael J McConnellBrain Somatic Mosaicism Network
Aug 25, 2017·Human Gene Therapy·Céline VandammeFederico Mingozzi
Nov 2, 2017·The New England Journal of Medicine·Jerry R MendellBrian K Kaspar
Jul 18, 2018·Nature Medicine·Giulia MassaroAhad A Rahim
Aug 18, 2018·Seminars in Perinatology·Neeta L Vora, Ronald Wapner
Feb 20, 2019·Nature Medicine·Christopher E NelsonCharles A Gersbach
Mar 5, 2019·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Desheng LiangLingqian Wu
Apr 5, 2019·Neuron·Eloise Hudry, Luk H Vandenberghe
May 31, 2019·Molecular Autism·Monica SonzogniYpe Elgersma
Jul 18, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ylenia IngrasciottaGianluca Trifirò
Aug 11, 2019·Molecular Genetics & Genomic Medicine·Robert P CarsonJessica Duis

Related Concepts

Autistic Disorder
Gene Deletion
Gene Therapy
Prenatal Care
Oligonucleotides, Antisense

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.


Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Related Papers

American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
Wen-Hann Tan, Lynne Bird
Clinica Chimica Acta; International Journal of Clinical Chemistry
Michele Curcio, Silvano Presciuttini
American Journal of Medical Genetics. Part a
Craig A EricksonDebomoy K Lahiri
© 2021 Meta ULC. All rights reserved